SELUTION DENOVO presented at #TCT2025. 💥 target vessel failure at 1 yr: 5.3% in sirolimus-eluting ballon arm vs. 4.4% in DES arm (meeting 50% non-inferiority margin) @divaka_perera reviews data and takes a deep dive with @DrPeterOKane and @twj1974 https://t.co/is7TqOI5AE

🚨@REVIVED_BCIS2 scar analysis🫀 ➡️Scar volume & pattern highly associated with death and arrhythmia ➡️Scar assessment should be routine, particularly in those at borderline risk Out now @JACCJournals CVI🔗 https://t.co/Q3BiRblDiJ 📺Watch our summary👇 https://t.co/J9Ij5nJQBn

This first randomized comparison of FFR & iFR in serial #cvCAD shows that both FFR & iFR pullbacks overestimate hemodynamic benefits of #PCI. Post-PCI physiology should be routinely performed in diffuse & serial disease. https://t.co/oKY788cJrE @divaka_perera @mattlkw #JACCINT

@JACCJournals @kingscardio @divaka_perera @DrOzanDemir @ColletCarlos @SaadEzad @GSTTnhs @DrBModi @DrPeterOKane @NickCurzen @DamienCollison @K_DeSilva @UKheartresearch

🚨FFR and iFR systematically overestimate the result of PCI in serial and diffuse coronary disease 🚨 #CoronaryPhysiology 🎲Randomised 👁️Blinded 🙋‍♀️Within patient comparison 🔗 Full link @JACCJournals https://t.co/AFHt3W4VbE 📺Watch our summary below👇

Pressure-Derived Indices in Left Main Coronary Artery Disease @CircIntv ➡️ PW indices differ significantly between the LAD and LCx in isolated LMCA due to inherent differences in microvascular resistance and coronary flow. 🔗 https://t.co/o4h3XpVZUl @TheBHF @kingscardio

@MGtberg @DrOzanDemir @CircIntv @TheBHF @kingscardio @DrHaseebRahman1 @sven_plein @ncurzen @ColletCarlos @monaltiren @JEscaned @SVRaoMD @BCIS_uk @K_DeSilva Cross talk not an issue as there was no pressure drop in the vessels beyond the LMCA. As close to normal epicardial conductance in LAD and LCx as virtually any reported data series. *btw we have some interesting data coming v soon on cross-talk https://t.co/oDlT5sz5G7 @mattlkw

🏴‍☠️CMD-HFpEF is a prevalent endotype of HFpEF ❌However, its pathophysiology remains incompletely understood ✅We discuss impaired lusitropy and subendocardial ischemia as the potential link between CMD and HFpEF https://t.co/kolKERqQJv

What is the role of revascularisation for ischaemic heart failure after REVIVED? Look today in ICR3 for thoughts from REVIVED chief investigator @divaka_perera and NEJM editorial author @ajaykirtane. https://t.co/pz96Au8ezN #ICRJournal @UKheartresearch @REVIVED_BCIS2 @SabaAssar

Absolute pleasure to be invited to speak at #BCJACore2023, an event that I found so useful not that long ago (and pick up some cardio-oncology tips too)! Good luck to all those sitting the exam this year. @TheBJCA @hollymorgs @cfcamm

Universities 'finalising' a data sharing agreement ...

British Cardiovascular Intervention Society Jeopardy Score calculator launched #aci2023 today! https://t.co/KeEME4zPcs allows quick, reliable quantification of extent of coronary disease to assess trial eligibility and stratify clinical risk. @CHIP_BCIS3 @REVIVED_BCIS2 @BCIS_uk

Congratulations @DrMattRyan et al for their insightful work on invasive viability assessment https://t.co/yZce3GYtD1. NON-invasive viability assessment under the microscope when @divaka_perera presents the REVIVED Viability Analysis at Late Breaking Trials #ACC23 on Sat 4 March

Excellent review article discussing the different physiological phenotypes of CAD https://t.co/JSst8JWBU2 and re-iterating that serial CAD represents a diagnostic challenge in the catheter lab https://t.co/DYr8cYnZuG @ColletCarlos @BernardBruyne @divaka_perera @DrBModi

There was no difference in the primary outcome at a median of 3.4 years, despite a high event rate in both arms.

In the 2nd row and the auditorium is packed. Apparently there is some trial being presented today? #ESCCongress @BlakeSarahR @hollymorgs @UKheartresearch @divaka_perera @REVIVED_BCIS2

Comparison of Flow Study (Doppler vs Thermo) ➡️CFR-thermo overestimates CFR-Doppler (modest correlation) ➡️Commonly used CFR-thermo threshold 2.0 has poor diagnostic accuracy ➡️Optimal CFR threshold 2.5 (thermo OR Doppler) 🔗 https://t.co/fyuK3PfRQT @JACCJournals #EuroPCR2022

In STEMI patients earlier treatment of non-culprit lesion during COVID‐19 pandemic associated with⬇️rates unplanned revascularization and myocardial infarction at 6⃣m f/u 🔗 https://t.co/djVdNM1wwO @LCC_DrMalik @divaka_perera @UKheartresearch @BCIS_uk @kingscardio @CCIJournal

Direct to cath lab or not after out of hospital cardiac arrest? A deep dive into COACT and TOMAHAWK here. #MedEd #CardioTwitter https://t.co/JiAFk7ukFl @DrNileshPareek @K_DeSilva @touchCARDIO @ukheartresearch @kingscardio

FLOWER-MI & root of the problem with non-culprit revascularisation @mattlkw @K_DeSilva @ColletCarlos @divaka_perera #OpenHeartBMJ #FLOWERMI https://t.co/E6UAWsrtrx